199 related articles for article (PubMed ID: 22159921)
1. The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer.
Gao J; Yang X; Yin P; Hu W; Liao H; Miao Z; Pan C; Li N
Int J Oncol; 2012 Apr; 40(4):1203-9. PubMed ID: 22159921
[TBL] [Abstract][Full Text] [Related]
2. Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells.
Gao J; Zheng Z; Rawal B; Schell MJ; Bepler G; Haura EB
Cancer Biol Ther; 2009 Sep; 8(17):1671-9. PubMed ID: 19633423
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.
Hu J; Deng H; Friedman EA
Int J Cancer; 2013 May; 132(10):2258-69. PubMed ID: 23114871
[TBL] [Abstract][Full Text] [Related]
4. Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis.
Chen Y; Wang S; He Z; Sun F; Huang Y; Ni Q; Wang H; Wang Y; Cheng C
Hum Pathol; 2017 Aug; 66():48-58. PubMed ID: 28554575
[TBL] [Abstract][Full Text] [Related]
5. Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/RB2.
Hu J; Nakhla H; Friedman E
Int J Cancer; 2011 Jul; 129(2):307-18. PubMed ID: 20857490
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.
Ewton DZ; Hu J; Vilenchik M; Deng X; Luk KC; Polonskaia A; Hoffman AF; Zipf K; Boylan JF; Friedman EA
Mol Cancer Ther; 2011 Nov; 10(11):2104-14. PubMed ID: 21878655
[TBL] [Abstract][Full Text] [Related]
7. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
8. Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.
Deng X; Hu J; Ewton DZ; Friedman E
Carcinogenesis; 2014 Sep; 35(9):1968-76. PubMed ID: 24590896
[TBL] [Abstract][Full Text] [Related]
9. Mirk/Dyrk1B mediates G0/G1 to S phase cell cycle progression and cell survival involving MAPK/ERK signaling in human cancer cells.
Gao J; Zhao Y; Lv Y; Chen Y; Wei B; Tian J; Yang Z; Kong F; Pang J; Liu J; Shi H
Cancer Cell Int; 2013 Jan; 13(1):2. PubMed ID: 23311607
[TBL] [Abstract][Full Text] [Related]
10. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
[TBL] [Abstract][Full Text] [Related]
11. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
Jin K; Park S; Ewton DZ; Friedman E
Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193
[TBL] [Abstract][Full Text] [Related]
12. Hippo/Mst1 stimulates transcription of the proapoptotic mediator NOXA in a FoxO1-dependent manner.
Valis K; Prochazka L; Boura E; Chladova J; Obsil T; Rohlena J; Truksa J; Dong LF; Ralph SJ; Neuzil J
Cancer Res; 2011 Feb; 71(3):946-54. PubMed ID: 21245099
[TBL] [Abstract][Full Text] [Related]
13. Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial cell migration and is negatively regulated by the Met adaptor Ran-binding protein M.
Zou Y; Lim S; Lee K; Deng X; Friedman E
J Biol Chem; 2003 Dec; 278(49):49573-81. PubMed ID: 14500717
[TBL] [Abstract][Full Text] [Related]
14. Mirk/dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation.
Deng X; Ewton DZ; Mercer SE; Friedman E
J Biol Chem; 2005 Feb; 280(6):4894-905. PubMed ID: 15546868
[TBL] [Abstract][Full Text] [Related]
15. Mirk/Dyrk1B: a multifunctional dual-specificity kinase involved in growth arrest, differentiation, and cell survival.
Mercer SE; Friedman E
Cell Biochem Biophys; 2006; 45(3):303-15. PubMed ID: 16845176
[TBL] [Abstract][Full Text] [Related]
16. FOXO1 and FOXO3a sensitize non-small-cell lung cancer cells to cisplatin-induced apoptosis independent of Bim.
Sun T; Zhang J; Deng B; Fan X; Long T; Jin H; Tao S; Kang P; Tan Q
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1348-1359. PubMed ID: 33167006
[TBL] [Abstract][Full Text] [Related]
17. Mirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts.
Mercer SE; Ewton DZ; Deng X; Lim S; Mazur TR; Friedman E
J Biol Chem; 2005 Jul; 280(27):25788-801. PubMed ID: 15851482
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing variants of dual specificity tyrosine phosphorylated and regulated kinase 1B exhibit distinct patterns of expression and functional properties.
Leder S; Czajkowska H; Maenz B; De Graaf K; Barthel A; Joost HG; Becker W
Biochem J; 2003 Jun; 372(Pt 3):881-8. PubMed ID: 12633499
[TBL] [Abstract][Full Text] [Related]
19. The kinase Mirk is a potential therapeutic target in osteosarcoma.
Yang C; Ji D; Weinstein EJ; Choy E; Hornicek FJ; Wood KB; Liu X; Mankin H; Duan Z
Carcinogenesis; 2010 Apr; 31(4):552-8. PubMed ID: 20042639
[TBL] [Abstract][Full Text] [Related]
20. Mirk/dyrk1B is a Rho-induced kinase active in skeletal muscle differentiation.
Deng X; Ewton DZ; Pawlikowski B; Maimone M; Friedman E
J Biol Chem; 2003 Oct; 278(42):41347-54. PubMed ID: 12902328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
